期刊文献+

TLR3 gene polymorphisms in cancer:a systematic review and meta-analysis 被引量:2

TLR3 gene polymorphisms in cancer:a systematic review and meta-analysis
下载PDF
导出
摘要 Introduction:Recent studies examining the association of Toll-like receptor 3(TLR3)gene polymorphisms with the risk of developing various types of cancer have reported conflicting results.Clarifying this association could advance our knowledge of the influence of TLR3 single nucleotide polymorphisms(SNPs)on cancer risk.Methods:We systematically reviewed studies that focused on a collection of 12 SNPs located in the TLR3 gene and the details by which these SNPs influenced cancer risk.Additionally,14 case-control studies comprising a total of7997 cases of cancer and 8699 controls were included in a meta-analysis of 4 highly studied SNPs(rs3775290,rs3775291,rs3775292,and rs5743312).Results:The variant TLR3 genotype rs5743312(C9948T,intron 3,C>T)was significantly associated with an increased cancer risk as compared with the wild-type allele(odds ratio[OR]=1.11,95%confidence interval[CI]=1.00–1.24,P=0.047).No such association was observed with other TLR3 SNPs.In the stratified analysis,the rs3775290(C13766T,C>T)variant genotype was found to be significantly associated with an increased cancer risk in Asian populations.Additionally,the rs3775291(G13909A,G>A)variant genotype was significantly associated with an increased cancer risk in Asians,subgroup with hospital-based controls,and subgroup with a small sample size.Conclusion:After data integration,our findings suggest that the TLR3 rs5743312 polymorphism may contribute to an increased cancer risk. Introduction: Recent studies examining the association of Toll-like receptor 3 (TLR3) gene polymorphisms with the risk of developing various types of cancer have reported conflicting results. Clarifying this association could advance our knowledge of the influence of TLR3 single nucleotide polymorphisms (SNPs) on cancer risk. Methods: We systematically reviewed studies that focused on a collection of 12 SNPs located in the TLR3 gene and the details by which these SNPs influenced cancer risk. Additionally, 14 case-control studies comprising a total of 7997 cases of cancer and 8699 controls were included in a meta-analysis of 4 highly studied SNPs (rs3775290, rs3775291, rs3775292, and rs5743312). Results: The variant TLR3 genotype rs5743312 (C9948T, intron 3, C 〉 T) was significantly associated with an increased cancer risk as compared with the wild-type allele (odds ratio [OR] = 1.11, 95 % confidence interval [CI] = 1.00-1.24, P = 0.047). No such association was observed with other TLR3 SNPs. In the stratified analysis, the rs3775290 (C13766T, C 〉 T) variant genotype was found to be significantly associated with an increased cancer risk in Asian populations. Additionally, the rs3775291 (G13909A, G 〉 A) variant genotype was significantly associated with an increased cancer risk in Asians, subgroup with hospital-based controls, and subgroup with a small sample size. Conclusion: After data integration, our findings suggest that the TLR3 rs5743312 polymorphism may contribute to an increased cancer risk.
机构地区 Department
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2015年第6期8-20,共13页
关键词 基因多态性 癌症 系统 单核苷酸多态性 TOLL样受体 SNPS 基因变异 等位基因 Ben-Gang Wang, De-Hui Yi and Yong-Feng Liu
  • 相关文献

参考文献27

  • 1Zhang SY, Herman M, Ciancanelli MJ, Perez de Diego R, Sancho-Shimizu V,Abel L, et al. TLR3 immunity to infection in mice and humans. Curr OpinImmunol. 2013;25:19–33.
  • 2Frazao JB, Errante PR, Condino-Neto A. Toll-like receptors’ pathwaydisturbances are associated with increased susceptibility to infections inhumans. Arch Immunol Ther Exp (Warsz). 2013;61:427–43.
  • 3Netea MG, Wijmenga C, O’Neill LA. Genetic variation in Toll-like receptorsand disease susceptibility. Nat Immunol. 2012;13:535–42.
  • 4He JF, Jia WH, Fan Q, Zhou XX, Qin HD, Shugart YY, et al. Geneticpolymorphisms of TLR3 are associated with nasopharyngeal carcinoma riskin Cantonese population. BMC Cancer. 2007;7:194.
  • 5Singh V, Srivastava N, Kapoor R, Mittal RD. Single-nucleotide polymorphismsin genes encoding Toll-like receptor-2, -3, -4, and -9 in a case-control studywith bladder cancer susceptibility in a North Indian population. Arch MedRes. 2013;44:54–61.
  • 6Mandal RK, George GP, Mittal RD. Association of Toll-like receptor (TLR) 2, 3and 9 genes polymorphism with prostate cancer risk in North Indianpopulation. Mol Biol Rep. 2012;39:7263–9.
  • 7Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P, et al. Evaluationof Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms incervical cancer susceptibility. Mol Biol Rep. 2011;38:4715–21.
  • 8Etokebe GE, Knezevic J, Petricevic B, Pavelic J, Vrbanec D, Dembic Z.Single-nucleotide polymorphisms in genes encoding toll-like receptor-2,-3, -4, and -9 in case-control study with breast cancer. Genet Test MolBiomarkers. 2009;13:729–34.
  • 9Li G, Zheng Z. Toll-like receptor 3 genetic variants and susceptibility tohepatocellular carcinoma and HBV-related hepatocellular carcinoma.Tumour Biol. 2013;34:1589–94.
  • 10Mantel N, Haenszel W. Statistical aspects of the analysis of data fromretrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

同被引文献8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部